New Hope Network is part of the Informa Markets Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

In Session

Genomics: Riding the future wave of supplements

Personalization and diagnostics are going to vet out what’s real and what’s not in the supplement industry
Personalization and diagnostics are going to vet out what’s real and what’s not in the supplement industry, according to supplement industry veteran Tom Aarts. Join him and Roberta Kline of Genoma International to better understand this exciting area of science that’s changing how we look at health.

“Interpretation of genomic testing is vastly underrated: it takes a lot to put this information together in a way that makes sense for a patient, and that to me is the biggest challenge in the industry today.”

—Roberta Kline, MD, Genoma International

Part 1: Gene testing: what, when and how

Highlights:

  • Why gene testing can make a big difference for vitamin intake.
  • What one Silicon Valley company is doing to bring personalization to the masses. 
  • Those who get into personalization will be some of the winners in the supplement space.

 

Part 2: Personalization for the consumer

Highlights:

  • Tests range from lowest-cost off-the-shelf to premium individualized solutions.
  • Some biomarker tests are already on store shelves/sold direct-to-consumer (DTC). 
  • How to engage consumers and tackle a 73 percent throwaway rate for wearable devices.

 

Part 3: Genetic testing by the numbers

Highlights:

  • In the next five years, consumers will have access to their genomes for less than  $1,000 (compared with $2,000-plus today).
  • In 2017, direct-to-consumer genetic tests more than doubled and now exceed 12 million people, mostly in the U.S.
  • Direct-to-consumer genetic testing market growth is estimated to go from roughly $70 million in 2015 to $340 million by 2022.

 

Part 4: The mighty microbiome

Highlights:

  • Understanding the microbiome could be the key to everything.
  • Saliva testing for the microbiome could be a big disruptor in the industry.

 

Part 5: The end of one size fits all

Highlights:

  • Genetics vs. genomics: They’re not the same.
  • Why DNA is important: It’s all about the SNPs.

 

Part 6: Nutritional genomics: The food-gene conversation

Highlights:

  • Nutritional needs vary based on individual DNA.
  • One simple thing like fasting can have a huge ripple effect on our health. 
  • EPA/DHA is a big challenge for vegans, with gene SNPs that can impair the process.

 

Part 7: A personalized health roadmap

Highlights:

  • Particularly transformative with illness, genomics can jump-start the healing process.
  • Get actionable information and a proprietary map you can take anywhere.

 

This session—Technologies & Discoveries Driving Personalized Nutrition—was recorded at Natural Products Expo West 2018. Click "download" below to access the presentation slides.

Hide comments
account-default-image

Comments

  • Allowed HTML tags: <em> <strong> <blockquote> <br> <p>

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Publish